T. Rowe Price Associates’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.6M | Buy |
|
|||||
|
2025
Q4 | $27.4M | Buy |
|
|||||
|
2025
Q3 | $312K | Buy |
|
|||||
|
2025
Q2 | $128K | Buy |
|
|||||
|
2025
Q1 | $66K | Sell |
|
|||||
|
2024
Q4 | $153K | Sell |
|
|||||
|
2024
Q3 | $376K | Buy |
|
|||||
|
2024
Q2 | $339K | Buy |
|
|||||
|
2024
Q1 | $298K | Buy |
|
|||||
|
2023
Q4 | $348K | Sell |
|
|||||
|
2023
Q3 | $480K | Sell |
|
|||||
|
2023
Q2 | $550K | Buy |
|
|||||
|
2023
Q1 | $203K | Sell |
|
|||||
|
2022
Q4 | $168K | Hold |
|
|||||
|
2022
Q3 | $190K | Hold |
|
|||||
|
2022
Q2 | $279K | Sell |
|
|||||
|
2022
Q1 | $302K | Buy |
|
|||||
|
2021
Q4 | $657K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $241K | Buy |
|
|||||
|
2021
Q1 | $280K | Buy |
|